Skip to content

Comparison of the efficacy of radial shock wave therapy versus ultrasound therapy on pain reduction in patients with knee osteoarthritis

Comparison of the efficacy of radial shock wave therapy versus ultrasound therapy on pain reduction in patients with knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160125001
Enrollment
32
Registered
2016-01-25
Start date
2015-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoathritis osteoathritis

Interventions

Radial extracorporeal shockwave treatment uses low to medium energy shockwaves generated when a projectile is accelerated by compressed air and hits an applicator. These impulses are delivered into th
Experimental Procedure/Surgery,Experimental Procedure/Surgery
Shockwave therapy ,Ultrasound

Sponsors

Siriraj hospital
Lead Sponsor
Siriraj hospital,Siriraj hospital
Collaborator

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults over the age of 50 years with primary symptomatic knee OA according to the criteria of the American College of Rheumatology Kellgren and Lawrence grade 2-3 Able to ambulate Moderate to severe knee pain[VAS > 5]

Exclusion criteria

Exclusion criteria: Knee joint disease other than OA History of spinal stenosis Evidence of neurologic disease by history or physical examination Secondary causes of arthritis (inflammatory or metabolic) History of a surgical intervention or intra-articular injection in the affected knee in the previous 6 months Any contraindication to radiography Serious psychiatric disorder Cognitive dysfunction or could not cooperate or communicate Unwillingness to accept either of the interventions in this studyOver metal implants On cardiac pace maker Pregnancy Thrombosis Coagulation disorders(haemophilia) Use of anticoagulant drugs (except low dose Aspirin) Malignancy Acute inflammation in the area of treatment

Design outcomes

Primary

MeasureTime frame
VAS 4week VAS

Secondary

MeasureTime frame
WOMAC score 4week WOMAC score

Countries

Thailand

Contacts

Public ContactWalailak Kulthai

siriraj hospital

donghae_teuk@hotmail.com66846627076

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026